Cytokinetics appoints James M. Daly to Board of Directors as Class III member

CYTOKINETICS INC

James M. Daly appointed to Board effective August 19, 2025, as Class III director, term expiring at 2028 annual meeting.
Daly also appointed to Compliance Committee; determined independent under SEC and Nasdaq rules.
Annual director compensation: $50,000 retainer, $7,500 Compliance retainer, plus $440,000 equity grant.
Initial option grant of 27,450 shares ($700,000 fair value) vesting over three years.
No arrangements or transactions requiring disclosure under Item 404(a).

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0000950170-25-110368
form_type: 8-K
ticker: CYTK
cik: 0001061983
company_name: CYTOKINETICS INC
filed_at: 2025-08-20T23:59:59+00:00
discovered_at: 2026-05-14T18:02:43.228653+00:00
generated_at: 2026-05-17T11:03:31.822365+00:00
sec_items: ["5.02"]
event_type: leadership
sentiment: neutral
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0000950170-25-110368
json_url: https://secwatch.observer/filing/0000950170-25-110368.json
markdown_url: https://secwatch.observer/filing/0000950170-25-110368.md
text_url: https://secwatch.observer/filing/0000950170-25-110368.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/1061983/000095017025110368/0000950170-25-110368-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/1061983/000095017025110368/cytk-20250819.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

Alpha Teknova director Irene Davis to retire; board reduced from 8 to 7; shareholder votes approved nominees and auditor

Alpha Teknova, Inc. June 1, 2026, 5:22 PM ET leadership Items 5.02, 5.07, 9.01